Is nMP22 a sensitive , cost-effective test in patients at risk for bladder cancer?
This study indicates that urinary NMP22 is a simple, noninvasive, cost-effective marker for the detection of bladder cancer.
There is no best time point applying to all markers for collecting blood samples after aerobic exercise. The optimum postexercise time points for blood collection in untrained individuals are immediately after exercise for catalase, 1 h for TBARS, 2 h for TAC, GSH, and GSSG, and 4 h after exercise for protein carbonyls.